Andreas Lutterotti

Andreas Lutterotti

UNVERIFIED PROFILE

Are you Andreas Lutterotti?   Register this Author

Register author
Andreas Lutterotti

Andreas Lutterotti

Publications by authors named "Andreas Lutterotti"

Are you Andreas Lutterotti?   Register this Author

43Publications

981Reads

20Profile Views

Autoantibodies against the prion protein in individuals with mutations.

Neurology 2020 Feb 25. Epub 2020 Feb 25.

From the Institute of Neuropathology (K.F., M.C., M.L., M.E., S. Hornemann, A.A.), Institute of Surgical Pathology (U.C.), and Department of Neurology, Neuroimmunology and MS Research (NIMS) (A.L.), University of Zurich, Switzerland; Department of Chemistry (G.M., T.K.), University of Cambridge, UK; CJD Foundation Israel (A.A.), Pardes Hanna; ICM (J.-P.B.), Salpêtrière Hospital, Sorbonne University, Paris, France; CIC bioGUNE and IKERBASQUE (J.C.), Basque Foundation for Science, Bizkaia, Spain; Sorbonne University (S. Haïk), ICM, Salpêtrière Hospital, Paris, France; Ophthalmology Division (E.L.), University of Graz, Austria; Broad Institute (E.V.M.), Cambridge, MA; Treviso Hospital (I.R.), Italy; Department of Pathology, Neurology, and National Prion Disease Pathology Surveillance Center (J.G.S.), Case Western Reserve University, Cleveland, OH; Alzheimer's Disease and Other Cognitive Disorders Unit (R.S.-V.), Hospital Clinic, IDIBAPS, University of Barcelona, Spain; and Department of Prion Diseases (D.Ž.), Slovak Medical University, Bratislava, Slovakia.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/WNL.0000000000009183DOI Listing
February 2020

Pathophysiological and cognitive mechanisms of fatigue in multiple sclerosis.

J Neurol Neurosurg Psychiatry 2019 06 25;90(6):642-651. Epub 2019 Jan 25.

Translational Neuromodeling Unit (TNU), Institute for Biomedical Engineering, University of Zurich and ETH Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1136/jnnp-2018-320050DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6581095PMC
June 2019

Unfavorable Structural and Functional Outcomes in Myelin Oligodendrocyte Glycoprotein Antibody-Associated Optic Neuritis.

J Neuroophthalmol 2019 Mar;39(1):3-7

Neuroimmunology and Multiple Sclerosis Research (IJ, JVMH, SL, RM, AL, and SS), Neurology Clinic, University Hospital Zurich, University of Zurich, Zurich, Switzerland; Department of Ophthalmology (JVMH, KPW, and KL), University Hospital Zurich, Zurich, Switzerland; Department of Ophthalmology (MP), Luzerner Kantonsspital, Lucerne, Switzerland; Clinical Department of Neurology (MR), Medical University of Innsbruck, Innsbruck, Austria; and Neurology Clinic (MW, KPW), University Hospital Zurich, University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://Insights.ovid.com/crossref?an=00041327-900000000-9923
Publisher Site
http://dx.doi.org/10.1097/WNO.0000000000000669DOI Listing
March 2019

Change of olfactory function as a marker of inflammatory activity and disability progression in MS.

Mult Scler 2019 02 29;25(2):267-274. Epub 2017 Nov 29.

Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria/Department of Neurology, University Hospital Zurich, Zurich, Switzerland; University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458517745724DOI Listing
February 2019

Transient impairment of olfactory threshold in acute multiple sclerosis relapse.

Mult Scler Relat Disord 2018 Jul 26;23:74-77. Epub 2018 May 26.

Department of Neurology, Medical University of Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.msard.2018.05.006DOI Listing
July 2018

Challenges and needs in experimental therapies for multiple sclerosis.

Curr Opin Neurol 2018 06;31(3):263-267

Andreas Lutterotti, Neurology Clinic, University Hospital Zurich & University of Zurich, Frauenklinikstrasse, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/WCO.0000000000000560DOI Listing
June 2018

Is it Time for Immunotherapy Trials in Narcolepsy?

J Clin Sleep Med 2017 03 15;13(3):363-364. Epub 2017 Mar 15.

Department of Neurology, University Hospital Zurich and University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.5664/jcsm.6478DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5337581PMC
March 2017

CD4+ T-Cell Reactivity to Orexin/Hypocretin in Patients With Narcolepsy Type 1.

Sleep 2017 Mar;40(3)

Clinical Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, A-6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/sleep/zsw070DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5806576PMC
March 2017

Restoring immune tolerance in neuromyelitis optica: Part I.

Neurol Neuroimmunol Neuroinflamm 2016 Oct 7;3(5):e276. Epub 2016 Sep 7.

Department of Neurology (L.S.), Stanford University School of Medicine, Palo Alto, CA; Neuroimmunology Unit and Experimental Therapeutics Program (A.B.-O.), Montreal Neurological Institute and Hospital, McGill University, Montreal, Canada; The Guthy-Jackson Charitable Foundation (J.M.B.), San Diego, CA; Department of Gastroenterology (D.B.-R., P.V.), Hospital Clínic, CIBERehd and Center of Neuroimmunology & Inflammatory Bowel Disease, Institut d'Investigacions Biomèdiques August Pi Sunyer (IDIBAPS), Barcelona, Spain; Genentech, Inc. (P.S.C.), South San Francisco, CA; Department of Pathology (M.C.-S.), University of Florida School of Medicine, Gainesville; Opexa Therapeutics (D.H.), The Woodlands, TX; Department of Surgery (J.I.K.), Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Department of Biochemistry (D.M.K.), University of Illinois, Urbana; Neuroimmunology and MS Research (A.L., R.M., S.S.), Department of Neurology, University Hospital Zurich, University Zurich, Switzerland; Forest Landing Court (H.L.W.), Rockville, MD; Ann Romney Center for Neurologic Diseases (S.S.Z.), Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Department of Neurology and Program in Immunology (H.L.W.), University of California, San Francisco School of Medicine; Department of Medicine (S.S.Z.), Divisions of Molecular Medicine & Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles; Harbor-UCLA Medical Center & LABioMed at Harbor-UCLA Medical Center (M.R.Y.), Torrance, CA; Department of Ophthalmology and Visual Sciences, Kellogg Eye Center, and Division of Metabolism and Endocrine Diseases, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor (T.J.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000276DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015539PMC
October 2016

Restoring immune tolerance in neuromyelitis optica: Part II.

Neurol Neuroimmunol Neuroinflamm 2016 Oct 7;3(5):e277. Epub 2016 Sep 7.

Neuroimmunology Unit and Experimental Therapeutics Program (A.B.-O.), Montreal Neurological Institute and Hospital, McGill University, Montreal, Canada; Department of Neurology (L.S.), Stanford University School of Medicine, Palo Alto; The Guthy-Jackson Charitable Foundation (J.M.B.), San Diego, CA; Department of Gastroenterology (D.B.-R., P.V.), Hospital Clínic, CIBERehd and Center of Neuroimmunology & Inflammatory Bowel Disease, Institut d'Investigacions Biomèdiques August Pi Sunyer, Barcelona, Spain; Genentech, Inc. (P.S.C.), South San Francisco, CA; Department of Pathology (M.C.-S.), University of Florida School of Medicine, Gainesville; Opexa Therapeutics (D.H.), The Woodlands, TX; Department of Surgery (J.I.K.), Center for Transplantation Sciences, Massachusetts General Hospital, Harvard Medical School, Boston, MA; Department of Biochemistry (D.M.K.), University of Illinois, Urbana; Neuroimmunology and MS Research (A.L., R.M., S.S.), Department of Neurology, University Hospital Zurich, University Zurich, Switzerland; Ann Romney Center for Neurologic Diseases (H.L.W.), Department of Neurology, Brigham and Women's Hospital, Harvard Medical School, Boston, MA; Department of Neurology and Program in Immunology (S.S.Z.), University of California, San Francisco School of Medicine; Department of Ophthalmology and Visual Sciences (T.J.S.), Kellogg Eye Center, and Division of Metabolism, Endocrine and Diabetes, Department of Internal Medicine, University of Michigan Medical School, Ann Arbor; Department of Medicine (M.R.Y.), Divisions of Molecular Medicine & Infectious Diseases, David Geffen School of Medicine at UCLA, Los Angeles; and Harbor-UCLA Medical Center & LABioMed at Harbor-UCLA Medical Center (M.R.Y.), Torrance, CA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000277DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5015540PMC
October 2016

Orbital Pseudotumor as a Rare Extrahepatic Manifestation of Hepatitis C Infection.

Case Rep Gastroenterol 2016 Jan-Apr;10(1):108-14. Epub 2016 May 19.

Division of Ophthalmology, University Hospital Zurich, University of Zurich, Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1159/000444011DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4929361PMC
July 2016

Rituximab induces clonal expansion of IgG memory B-cells in patients with inflammatory central nervous system demyelination.

J Neuroimmunol 2016 Jan 19;290:49-53. Epub 2015 Nov 19.

Clinical Department of Neurology, Medical University of Innsbruck, Innsbruck, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2015.11.006DOI Listing
January 2016

NMDA receptor antibodies: A rare association in inflammatory demyelinating diseases.

Neurol Neuroimmunol Neuroinflamm 2015 Oct 13;2(5):e141. Epub 2015 Aug 13.

Clinical Department of Neurology (M. Ramberger, G.B., K.S., A.L., F.D., T.B., M. Reindl) and Department of Pediatrics I (K.R., M.B.), Medical University of Innsbruck, Austria; Institute of Neurology (R.H.), Medical University of Vienna, Austria; Pediatric Neurology (K.R.), Witten/Herdecke University, Children's Hospital Datteln, Datteln, Germany; Department of Neurology (F.A.-D.), Karl Landsteiner Institute for Neuroimmunological and Neurodegenerative Disorders, Sozialmedizinisches Zentrum Ost Donauspital, Vienna, Austria; and Neuroimmunology and Multiple Sclerosis Research (A.L.), Department of Neurology, University Hospital Zurich and University of Zurich, Switzerland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1212/NXI.0000000000000141DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4537309PMC
October 2015

Impact of glatiramer acetate on paraclinical markers of neuroprotection in multiple sclerosis: A prospective observational clinical trial.

J Neuroimmunol 2015 Oct 10;287:98-105. Epub 2015 Aug 10.

Clinical Department of Neurology, Medical University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria; Clinics for Neurological Rehabilitation Münster, Groeben 700, 6232 Münster, Austria; Department of Radiology, Medical University Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2015.08.004DOI Listing
October 2015

Antibody responses following induction of antigen-specific tolerance with antigen-coupled cells.

Mult Scler 2015 Apr 8;21(5):651-5. Epub 2014 Sep 8.

Clinical Department of Neurology, Innsbruck Medical University, Austria/Neuroimmunology and Multiple Sclerosis Research, Department of Neurology, University Hospital Zurich, Switzerland

View Article

Download full-text PDF

Source
http://journals.sagepub.com/doi/10.1177/1352458514549405
Publisher Site
http://dx.doi.org/10.1177/1352458514549405DOI Listing
April 2015

Antigen-specific tolerization approaches in multiple sclerosis.

Expert Opin Investig Drugs 2014 Jan 23;23(1):9-20. Epub 2013 Oct 23.

Clinical Department of Neurology, Innsbruck Medical University, Innsbruck , Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1517/13543784.2014.844788DOI Listing
January 2014

Clinical and immunological follow-up of B-cell depleting therapy in CNS demyelinating diseases.

J Neurol Sci 2013 May 21;328(1-2):77-82. Epub 2013 Mar 21.

Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2013.02.024DOI Listing
May 2013

Persistency of neutralizing antibodies depends on titer and interferon-beta preparation.

Mult Scler 2012 May 19;18(5):610-5. Epub 2011 Oct 19.

Clinical Department of Neurology, Innsbruck Medical University, Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1177/1352458511426738DOI Listing
May 2012

Natalizumab treatment reduces endothelial activity in MS patients.

J Neuroimmunol 2010 Oct 23;227(1-2):190-4. Epub 2010 Aug 23.

Department of Neurology, Innsbruck Medical University, Anichstrasse 35, 6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2010.07.012DOI Listing
October 2010

Features of intrathecal immunoglobulins in patients with multiple sclerosis.

J Neurol Sci 2010 Jan 13;288(1-2):147-50. Epub 2009 Oct 13.

Clinical Department of Neurology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2009.09.016DOI Listing
January 2010

Antigen-specific therapies in MS - Current concepts and novel approaches.

J Neurol Sci 2008 Nov 3;274(1-2):18-22. Epub 2008 Jul 3.

Institute for Neuroimmunology and Clinical MS Research (inims), Center for Molecular Neurobiology Hamburg, University Medical Center Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jns.2008.05.021DOI Listing
November 2008

EBNA1-specific T cells from patients with multiple sclerosis cross react with myelin antigens and co-produce IFN-gamma and IL-2.

J Exp Med 2008 Aug 28;205(8):1763-73. Epub 2008 Jul 28.

Laboratory of Viral Immunobiology, Christopher H. Browne Center for Immunology and Immune Diseases, The Rockefeller University, New York, NY 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1084/jem.20072397DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2525578PMC
August 2008

Getting specific: monoclonal antibodies in multiple sclerosis.

Lancet Neurol 2008 Jun;7(6):538-47

Institute for Neuroimmunology and Clinical MS Research, Center for Molecular Neurobiology Hamburg, University Medical Center Eppendorf, Hamburg, Germany.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/S1474-4422(08)70110-8DOI Listing
June 2008

Biological markers for multiple sclerosis.

Curr Med Chem 2007 ;14(18):1956-65

Clinical Department of Neurology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2174/092986707781368478DOI Listing
October 2007

Increased serum levels of soluble CD14 indicate stable multiple sclerosis.

J Neuroimmunol 2006 Dec 13;181(1-2):145-9. Epub 2006 Oct 13.

Clinical Department of Neurology, Innsbruck Medical University, Anichstrasse 35, A-6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.jneuroim.2006.09.002DOI Listing
December 2006

Epitope specificity of neutralizing antibodies against IFN-beta.

J Interferon Cytokine Res 2004 May;24(5):283-90

Department of Neurology, University of Innsbruck, Anichstrasse 35, 6020 Innsbruck, Austria.

View Article

Download full-text PDF

Source
http://www.liebertpub.com/doi/10.1089/107999004323065066
Publisher Site
http://dx.doi.org/10.1089/107999004323065066DOI Listing
May 2004